tert-Butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate

Catalog No. :
ACPKFV035
CAS No. :
1630906-73-8
Molecular Formula :
C13H21NO3
Molecular Weight :
239.32

IUPAC Name:tert-butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate

tert-Butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$218.00Login to see priceIn stockInquiry
250mg95%$364.00Login to see priceIn stockInquiry
1g95%$911.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate
IUPAC Nametert-butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate
MDL No.MFCD27987352
Molecular FormulaC13H21NO3
Molecular Weight239.32
SMILESO=C(OC(C)(C)C)NC1C2CC(CC1CC2)=O
InChI KeyUFRMIMOAWPURFR-UHFFFAOYSA-N
Synonymtert-butyl N-{3-oxobicyclo[3.2.1]octan-8-yl}carbamate;tert-Butyl (3-oxobicyclo[3.2.1]octan-8-yl)carbamate;Carbamic acid, N-(3-oxobicyclo[3.2.1]oct-8-yl)-, 1,1-dimethylethyl ester;tert-butyl N-(3-oxo-8-bicyclo[3.2.1]octanyl)carbamate;8-(Boc-amino)bicyclo[3.2.1]octan-3-one
CAS No.1630906-73-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPKFV035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPKFV035 route product structure diagram
    ACPKFV0351630906-73-8 In Stock
Inquiry

2. ACPKFV035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPKFV035 route product structure diagram
    ACPKFV0351630906-73-8 In Stock
Inquiry

Comments (0)